References
- Tan KA, Gupta P, Agarwal A, et al. State of science: choroidal thickness and systemic health. Surv Ophthalmol. 2016; DOI: 10.1016/j.survophthal.2016.02.007.
- Ferrara D, Waheed NK, Duker JS. Investigating the choriocapillaris and choroidal vasculature with new optical coherence tomography technologies. Prog Retin Eye Res. 2016;52:130–55.
- Laviers H, Zambarakji H. Enhanced depth imaging-OCT of the choroid: a review of the current literature. Graefes Arch Clin Exp Ophthalmol. 2014;252:1871–1883.
- Pakzad-Vaezi K, Or C, Yeh S, et al. Optical coherence tomography in the diagnosis and management of uveitis. Can J Ophthalmol. 2014;49:18–29.
- Baltmr A, Lightman S, Tomkins-Netzer O. Examining the choroid in ocular inflammation: a focus on enhanced depth imaging. J Ophthalmol. 2014;2014:459136.
- Mrejen S, Spaide RF. Optical coherence tomography: imaging of the choroid and beyond. Surv Ophthalmol. 2013;58:387–429.
- Mrejen S, Spaide RF. Imaging the choroid in uveitis. Int Ophthalmol Clin. 2012;52:67–81.
- Regatieri CV, Alwassia A, Zhang JY, et al. Use of optical coherence tomography in the diagnosis and management of uveitis. Int Ophthalmol Clin. 2012;52:33–43.
- Duru N, Altinkaynak H, Erten Ş, et al. Thinning of choroidal thickness in patients with rheumatoid arthritis unrelated to disease activity. Ocul Immunol Inflamm. 2016;24:246–253.
- Altinkaynak H, Duru N, Uysal BS, et al. Choroidal thickness in patients with systemic lupus erythematosus analyzed by spectral-domain optical coherence tomography. Ocul Immunol Inflamm. 2016;24:254–260.
- Wu K, Zhang X, Su Y, et al. Clinical characteristics of inflammatory choroidal neovascularization in a Chinese population. Ocul Immunol Inflamm. 2016;24:261–267.
- Goodwin JE. Glucocorticoids and the cardiovascular system. Adv Exp Med Biol. 2015;872:299–314.
- Essex RW, Wong J, Jampol LM, et al. Idiopathic multifocal choroiditis: a comment on present and past nomenclature. Retina. 2013;33:1–4.
- Spaide RF, Goldberg N, Freund KB. Redefining multifocal choroiditis and panuveitis and punctate inner choroidopathy through multimodal imaging. Retina. 2013;33:1315–1324.
- Mansour AM, Arevalo JF, Ziemssen F, et al. Long-term visual outcomes of intravitreal bevacizumab in inflammatory ocular neovascularization. Am J Ophthalmol. 2009;148:310–316.
- Arevalo JF, Adan A, Berrocal MH, et al.; Pan-American Collaborative Retina Study Group. Intravitreal bevacizumab for inflammatory choroidal neovascularization: results from the Pan-American Collaborative Retina Study Group at 24 months. Retina. 2011;31:353–363.
- Baxter SL, Pistilli M, Pujari SS, et al. Risk of choroidal neovascularization among the uveitides. Am J Ophthalmol. 2013;156:468–477.
- Cunningham ET Jr, Hubbard LD, Danis RP, et al. Proportionate topographic areas of retinal zones 1, 2, and 3 for use in describing infectious retinitis. Arch Ophthalmol. 2011;129:1507–1508.
- Fung AT, Pal S, Yannuzzi NA, et al. Multifocal choroiditis without panuveitis: clinical characteristics and progression. Retina. 2014;34:98–107.
- Baumal CR, de Carlo TE, Waheed NK, et al. Sequential optical coherence tomographic angiography for diagnosis and treatment of choroidal neovascularization in multifocal choroiditis. JAMA Ophthalmol. 2015;133:1087–1090.
- Amer R, Priel E, Kramer M. Spectral-domain optical coherence tomographic features of choroidal neovascular membranes in multifocal choroiditis and punctate inner choroidopathy. Graefes Arch Clin Exp Ophthalmol. 2015;253:949–957.
- Hoang QV, Cunningham ET Jr, Sorenson JA, et al. The “pitchfork sign” a distinctive optical coherence tomography finding in inflammatory choroidal neovascularization. Retina. 2013;33:1049–1055.